Target
CD276/B7-H3
6 abstracts
Abstract
The prognostic impact of transforming growth factor beta 2 (TGFB2) mRNA levels, in conjunction with interferon-gamma receptor activation of interferon regulatory factor 5 (IRF5) and expression of CD276/B7-H3 in low-grade gliomas.Org: Sapu Bioscience LLC, Oncotelic Therapeutics,
Abstract
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer.Org: Emory University School of Medicine and Winship Cancer Institute, Investigational Drug Branch, Winship Cancer Institute of Emory Univeristy,
Abstract
Pan-cancer associations of B7-H3 (CD276) transcriptional expression across human malignancies.Org: University of Minnesota Masonic Cancer Center, Minneapolis, MN, Caris Life Sciences, Irving, TX, Puerto Rico Medical Research Center, Barbara Ann Karmanos Cancer Institute, Huntsman Cancer Institute (NCI-CCC),
Abstract
ALAN as an omic tool to build gene signatures and to stratify patients.Org: University of Minnesota Masonic Cancer Center, Minneapolis, MN, Institute for Health Informatics, Academic Health Center,
Abstract
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).Org: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, University of Alabama at Birmingham Department of Hematology, Birmingham, AL, University of Alabama-Birmingham,
Abstract
Dysregulation of immune checkpoint proteins in patients with newly diagnosed early breast cancer undergoing neoadjuvant chemotherapy: A comparison between patients with triple negative breast cancer (TNBC) and non-TNBC.Org: The Medical Oncology Centre of Rosebank, Johannesburg, South Africa, Department of Immunology, Faculty of Health Science, University of Pretoria, Pretoria, South Africa, University of Pretoria, Department of Immunology, Pretoria, South Africa, Netcare, City of Johannesburg, South Africa, Drs Gritzman and Thatcher Inc. Pathology Laboratory, City of Johannesburg, South Africa,